This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,835.45 firm fixed-price delivery order is for the supply of a pharmaceutical product called "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML." The contract has an ultimate completion date of December 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's federal contract portfolio demonstrates its critical role in supplying essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and other medical supplies, to various federal healthcare programs and agencies.
Generated 3/18/25, 9:44 AM